[HTML] mdpi.com

[HTML][HTML] A critical analysis of the use of cilgavimab plus tixagevimab monoclonal antibody cocktail (Evusheld™) for COVID-19 prophylaxis and treatment

D Focosi, A Casadevall - Viruses, 2022 - mdpi.com
Evusheld®(tixagevimab+ cilgavimab; AZD7442) was the first anti-Spike monoclonal
antibody (mAb) cocktail designed not only for treatment but also with pre-exposure …
被引用次数：56 相关文章

A Critical Analysis of the Use of Cilgavimab plus Tixagevimab Monoclonal Antibody Cocktail (Evusheld™) for COVID-19 Prophylaxis and Treatment

D Focosi, A Casadevall - Viruses, 2022 - search.proquest.com
Evusheld®(tixagevimab+ cilgavimab; AZD7442) was the first anti-Spike monoclonal
antibody (mAb) cocktail designed not only for treatment but also with pre-exposure …

A critical analysis of the use of cilgavimab plus tixagevimab monoclonal antibody cocktail (Evusheld™) for COVID-19 prophylaxis and treatment.

D Focosi, A Casadevall - 2022 - cabidigitallibrary.org
Evusheld®(tixagevimab+ cilgavimab; AZD7442) was the first anti-Spike monoclonal
antibody (mAb) cocktail designed not only for treatment but also with pre-exposure …

A Critical Analysis of the Use of Cilgavimab plus Tixagevimab Monoclonal Antibody Cocktail (Evusheld™) for COVID-19 Prophylaxis and Treatment

D Focosi, A Casadevall - 2022 - agris.fao.org
Evusheld< sup>®</sup>(tixagevimab+ cilgavimab; AZD7442) was the first anti-Spike
monoclonal antibody (mAb) cocktail designed not only for treatment but also with pre …

A Critical Analysis of the Use of Cilgavimab plus Tixagevimab Monoclonal Antibody Cocktail (Evusheld™) for COVID-19 Prophylaxis and Treatment

D Focosi, A Casadevall - Viruses, 2022 - pubmed.ncbi.nlm.nih.gov
Evusheld®(tixagevimab+ cilgavimab; AZD7442) was the first anti-Spike monoclonal
antibody (mAb) cocktail designed not only for treatment but also with pre-exposure …

A Critical Analysis of the Use of Cilgavimab plus Tixagevimab Monoclonal Antibody Cocktail (Evusheld™) for COVID-19 Prophylaxis and Treatment.

D Focosi, A Casadevall - Viruses, 2022 - europepmc.org
Evusheld®(tixagevimab+ cilgavimab; AZD7442) was the first anti-Spike monoclonal
antibody (mAb) cocktail designed not only for treatment but also with pre-exposure …
[HTML] nih.gov

[HTML][HTML] A Critical Analysis of the Use of Cilgavimab plus Tixagevimab Monoclonal Antibody Cocktail (Evusheld™) for COVID-19 Prophylaxis and Treatment

D Focosi, A Casadevall - Viruses, 2022 - ncbi.nlm.nih.gov
Evusheld®(tixagevimab+ cilgavimab; AZD7442) was the first anti-Spike monoclonal
antibody (mAb) cocktail designed not only for treatment but also with pre-exposure …

A Critical Analysis of the Use of Cilgavimab plus Tixagevimab Monoclonal Antibody Cocktail (Evusheld™) for COVID-19 Prophylaxis and Treatment

D Focosi, A Casadevall - Viruses, 2022 - cir.nii.ac.jp
抄録< jats: p> Evusheld®(tixagevimab+ cilgavimab; AZD7442) was the first anti-Spike
monoclonal antibody (mAb) cocktail designed not only for treatment but also with pre …

A Critical Analysis of the Use of Cilgavimab plus Tixagevimab Monoclonal Antibody Cocktail (Evusheld™) for COVID-19 Prophylaxis and Treatment

D Focosi, A Casadevall - Viruses, 2022 - pure.johnshopkins.edu
Evusheld®(tixagevimab+ cilgavimab; AZD7442) was the first anti-Spike monoclonal
antibody (mAb) cocktail designed not only for treatment but also with pre-exposure …

A Critical Analysis of the Use of Cilgavimab plus Tixagevimab Monoclonal Antibody Cocktail (Evusheld™) for COVID-19 Prophylaxis and Treatment.

D Focosi, A Casadevall - Viruses (1999-4915), 2022 - search.ebscohost.com
Abstract Evusheld< sup>®</sup>(tixagevimab+ cilgavimab; AZD7442) was the first anti-
Spike monoclonal antibody (mAb) cocktail designed not only for treatment but also with pre …